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http:WHAT THIS PAPER ADDS
Acute kidney injury (AKI) is common following ruptured abdominal aortic aneurysm repair. The incidence of AKI
is higher after open repair than after endovascular repair, allaying previous concerns about the risk of contrast
nephropathy in these patients, and is associated with the level of aortic clamping during open repair. Patients
who experience signiﬁcant AKI suffer worse outcomes, so identiﬁcation of high-risk patients may lead to
improved patient outcomes from renal speciﬁc interventions in the peri- and early postoperative period.Introduction: Acute kidney injury (AKI) following ruptured abdominal aortic aneurysm (rAAA) repair is common
and multifactorial. A standard deﬁnition of AKI after endovascular repair (EVAR), the Aneurysm Renal Injury Score
(ARISe), has been proposed to facilitate standardised reporting and thus improve understanding of this issue.
Methods: Data were collected retrospectively on AKI in a prospectively maintained database of all patients
treated for rAAA in a single tertiary referral centre since the availability of routine out of hours emergency EVAR.
The ARISe score was used to describe the degree of AKI and factors which correlated with poor renal outcomes
were assessed.
Results: Two-hundred and ﬁve patients were treated between January 2006 and April 2014. Of these, 125 were
treated with open repair (OSR) and 80 were treated with EVAR. Severe AKI (deﬁned as ARISe score 3) occurred
in 36% of patients. After correction for confounders, patients treated with OSR were signiﬁcantly more likely to
develop severe AKI (43% vs. 26%, p ¼ .02). There was no signiﬁcant difference in preoperative serum creatinine
between groups, but increased preoperative serum creatinine was strongly associated with severe AKI
postoperatively (p < .001). Age, sex, endograft type, and preoperative CT scanning were not associated with
differences in renal outcomes. Clamp position above renal arteries was predictive of severe AKI in patients
treated with OSR (p < .01). Patients suffering severe AKI had signiﬁcantly higher mortality at 30 days and
12 months (28% vs. 5% and 44% vs. 13%, p < .001 for both comparisons).
Conclusion: Severe AKI is common following successful repair of rAAA. In this large case series of high-risk
patients, OSR was associated with signiﬁcantly higher rates of severe AKI compared with EVAR, despite the
increased dose of contrast involved in EVAR and the older age of these patients. In turn, severe AKI was
associated with higher mortality rates.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Recent advances in the treatment of abdominal aortic
aneurysm (AAA) have led to signiﬁcant improvements in
short-term mortality for elective repair, which has fallen to
around 2% in real world series.1 While outcomes following
ruptured AAA (rAAA) have also improved,2 mortalityrresponding author. Cambridge Vascular Unit, Cambridge University
ls NHS Foundation Trust, Hills Rd, Cambridge CB2 0QQ, UK.
il address: graeme.ambler@gmail.com (G.K. Ambler).
-5884/ 2015 European Society for Vascular Surgery. Published by
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//dx.doi.org/10.1016/j.ejvs.2015.06.024remains around 30% in modern series. One of the major
causes of short-term mortality is the multiple organ
dysfunction syndrome (MODS),6,7 with AKI being particu-
larly common.8 In turn, AKI increases longer-term cardio-
vascular risk and chronic kidney disease.9
AKI in the context of rAAA repair has a multifactorial
aetiology, with contributions arising from prolonged hypo-
volaemia, acute-on-chronic disease related to pre-existing
renovascular or other kidney disease, and contrast-
induced nephropathy in most patients, along with the
deliberate sacriﬁce of accessory renal arteries arising from
the aneurysm sac in some patients, although this latter
factor was not shown to have a signiﬁcant impact on
chronic kidney disease after elective EVAR.10 In addition,
those undergoing open repair (OSR) may have additional
444 G.K. Ambler et al.risk associated with supra-renal aortic clamping, while those
undergoing endovascular repair (EVAR) are likely to have a
signiﬁcantly higher contrast load.
One of the problems with the current literature on AKI
following AAA repair is the lack of a consensus on the way it
is reported.11 Some authors report serum creatinine values,
some use modern categorisations such as the RIFLE (Risk,
Injury, Failure, Loss, End-stage) classiﬁcation,12 some simply
report the requirement for temporary or permanent renal
replacement therapy. This plethora of different endpoints
makes reading confusing and attempts at meta-analysis
challenging. Recently, Twine et al. proposed a standard
deﬁnition: the ARISe (Aneurysm Renal Injury Score) classi-
ﬁcation (Table 1),11 which is based on the RIFLE classiﬁca-
tion but tailored towards aneurysm repair. Although they
proposed its use in the context of endovascular repair, it is
equally applicable to open surgery.
The aim of this study was to investigate the incidence of
AKI using the ARISe classiﬁcation at the study centre, and
the impact of AKI on short- and longer-term mortality and
length of stay.METHOD
Study population
All patients treated at Addenbrookes Hospital for ruptured
abdominal aortic aneurysm during the period January 1,
2006 until April 30, 2014 were included in the study. The
study period was chosen as it reﬂects the period following
the routine availability of out of hours emergency EVAR.
Follow-up was until July 2014. All patients were assessed
emergently by a consultant vascular surgeon and a decision
was made with regard to suitability for OSR or EVAR based
on patient factors (including haemodynamic stability) and
anatomical suitability, although no formal scoring system or
protocol was employed. Patients were selected for opera-
tive or non-operative treatment on clinical grounds at the
discretion of the treating surgeon. The operative team for
an EVAR consisted of a consultant vascular surgeon and a
consultant interventional radiologist and the EVAR was
performed in a standard operating theatre with a C arm.
Niopam 300 contrast was used for angiography in all EVAR
cases. The team for OSR consisted of a consultant vascular
surgeon and a senior general or vascular surgical trainee. An
anaesthetist (senior trainee or consultant grade) was alsoTable 1. Aneurysm Renal Injury Score (ARISe) classiﬁcation.11
Score Deﬁnition
1 Rise in serum creatinine > 26 mmol/L but < 50%
increase from baseline or urine output < 0.5 mL/
kg/h for 6 hours within 7 days
2 Rise in baseline serum creatinine 50e99% within
7 days
3 Rise in baseline serum creatinine  100% within
7 days
4 Requirement for temporary renal replacement
therapy
5 Permanent renal replacement therapypresent even for cases performed under local anaesthetic.
Immediate postoperative care was either in a high de-
pendency area or the intensive care unit depending on
clinical need, with step down to ward care as clinically
appropriate. Data on treatment for ruptured AAA in the unit
have been reported previously, including patients from the
earlier portion of the study period,5,13 but renal outcomes
have not been discussed previously. Data were collected as
part of routine service evaluation and no patient-
identiﬁable data are presented, so it was not deemed
necessary to seek ethical approval or retrospective consent
for the study.Data collected
The patient database has been prospectively maintained
since January 2006, including basic patient demographics,
comorbidity, medication history, length of stay, and mode of
repair. Further retrospective case note review was per-
formed to gather details of preoperative and intraoperative
haemodynamics (lowest systolic blood pressure and highest
pulse rate recorded prior to induction of anaesthesia and
after induction of anaesthesia or instillation of local
anaesthetic for those patients treated without general
anaesthesia), as well as renal outcomes and contrast vol-
umes where available for those patients treated with EVAR.
Contrast doses largely reﬂect the amount opened (in 50 mL
vials) rather than the amount which was actually used, as
the amount actually injected has only recently started to be
recorded. AKI rates were assessed in those patients sur-
viving for at least 24 hours following surgery, as it was felt
that it was not possible to accurately assess renal function
in those surviving for less than 24 hours. AKI was deﬁned as
‘severe’ if the patient suffered ARISe category 3 AKI. The
subset of these patients who required temporary or per-
manent renal replacement therapy was also examined.
An important issue when attempting to fulﬁl this aim re-
lates to adjustment for preoperative renal function in these
patients. Clearly, it would be optimal if glomerular ﬁltration
rate (GFR) could be assessed, or at least estimated GFR
(eGFR) in the preoperative phase. However, few patients
presenting with rAAA have had this assessed previously, and
the use of formulae to calculate eGFR is speciﬁcally recom-
mended against by nephrology associations in the acute
setting when serum creatinine is unlikely to be stable, as
these formulae were not developed for this purpose and
have never been validated in this setting.14 Therefore, we
elected to perform rigorous confounder adjustment by way
of appropriate multivariate models, incorporating serum
creatinine, demographic data, and comorbidities separately
rather than attempting to adjust for eGFR, which cannot be
assessed reliably for most patients.
Mortality data were updated using the hospital electronic
medical records system, which is linked to the United
Kingdom Ofﬁce for National Statistics.
To investigate the effects of clamp site on acute kidney
injury, mortality, and length of stay in patients treated with
OSR, a simple scoring system was introduced, the Level Of
Severe Renal Impairment following ruptured AAA repair 445Clamp (LOC) score, with zero points for an infra-renal clamp,
1 point for a trans-renal clamp, 2 points for a supra-renal
clamp, and 3 points for a clamp placed above either the
superior mesenteric or coeliac artery. This integer score
allowed examination of whether there was an incremental
difference in outcomes as the LOC increased. It was also
recorded whether the clamp was positioned at this level
only initially to gain control of bleeding during dissection, or
whether the clamp was positioned at this level while the
anastomosis was being sewn. Clamp position during anas-
tomosis was also used as a surrogate for whether an
aneurysm was infra-renal, and sensitivity analysis was per-
formed to look at whether comparisons between open and
endovascular repair were robust to the exclusion of patients
with a LOC score greater than zero. Division of the left renal
vein was also recorded, as was whether a tube graft or a
more complicated graft was used.Statistical analysis
Statistical analysis was performed using the R statistical
package version 3.1.1 together with the “survival” add-on
package. Fisher’s exact test was used to compare contin-
gency data, while the ManneWhitney U test was used to
assess the signiﬁcance of differences in continuous variables
between groups. The log rank test was used to test for
survival differences, and Cox proportional hazards model-
ling was used to adjust for confounders (age, gender, pre-
operative creatinine, history of ischaemic heart disease,
stroke/TIA, or diabetes, preoperative use of b-blockers or
statins, preoperative blood pressure and heart rate) in
terms of survival, while Poisson regression was used for this
adjustment when assessing for differences in length of stay
and logistic regression modelling was used when assessing
for differences in the incidence of severe AKI or require-
ment for renal replacement therapy. Cases with relevant
missing data were excluded from multivariate analysis.
RESULTS
Two-hundred and ﬁfty-ﬁve patients were treated for rAAA
between January 2006 and April 2014, of whom 205 were
treated operatively and 50 (19.6%) were palliated. One-
hundred and twenty-ﬁve were treated with OSR, whereasTable 2. Demographics, comorbidities, and preoperative medications
Parameter OSR
Age, median (IQR) 75 (
Male (%) 111 (
Lowest preoperative systolic blood pressure:
median (IQR), mmHg
80 (
Highest preoperative pulse rate:
median (IQR), bpm
85 (
Preop creatinine: median (IQR), mmol$L1 135 (
Previous ischaemic heart disease (%) 40 (
Previous stroke/TIA (%) 9 (
Pre-existing diabetes mellitus (%) 9 (
Preoperative b-blocker use (%) 25 (
Preoperative statin use (%) 60 (
TIA ¼ transient ischaemic attack.80 were treated with EVAR. Median follow-up for patients
surviving to the end of the study was 50 months (IQR 23e
74 months). Patients treated with EVAR were older than
those treated with OSR (median age 78 vs. 75 years,
respectively, p ¼ .046) and more likely to have a history of
ischaemic heart disease (47% vs. 32%, p ¼ .038), but
otherwise demographics, comorbidities and preoperative
medications were similar between these two groups
(Table 2). In particular, there was no signiﬁcant difference in
preoperative creatinine between these groups (p ¼ .62).
Patients treated with OSR had median lowest preoperative
systolic blood pressure of 80 mmHg (IQR 65e107),
compared with a median lowest preoperative systolic blood
pressure of 100 mmHg (IQR 81e124) in the EVAR group.
This difference was statistically signiﬁcant (p < .001).Acute kidney injury
None of the patients treated had received renal replace-
ment therapy prior to presentation. Severe AKI (deﬁned
above as ARISe category 3 AKI) occurred in 67 (36%) of
the 186 patients who survived for at least 24 hours
following surgery. Percentages below of patients suffering
severe AKI or requiring renal replacement therapy are
therefore based on a total of 186 patients rather than the
original 205. Fifty-four of these required temporary renal
replacement therapy. Only three patients (one in the OSR
group, two in the EVAR group) went on to require perma-
nent renal replacement therapy during the follow-up period
of the study. Signiﬁcantly more patients treated with OSR
suffered severe AKI than those treated with EVAR (43%
versus 26%, respectively, p ¼ .02). These differences
remained signiﬁcant after adjusting for confounders
(p ¼ .02), including measures of haemodynamic instability.
Patients treated with OSR also had a higher requirement for
temporary or permanent renal replacement therapy,
although this difference was not statistically signiﬁcant (36%
vs. 23%, adjusted p ¼ .12).
Other than the type of repair, the only signiﬁcant pre-
dictor of severe AKI was preoperative serum creatinine
(median [IQR] preoperative serum creatinine for those pa-
tients not suffering severe AKI: 121 [98e158] mmol$L1 vs.
147 [118e187] mmol$L1 in those suffering severe AKI;for patients treated by OSR or EVAR.
EVAR p
69e81) 78 (73e82) .046
88) 66 (83) .22
65e107) 100 (81e124) 8  105
70e105) 81 (70e95) .07
110e173) 129 (107e167) .62
32) 37 (47) .038
7) 8 (10) .60
7) 6 (8) 1.0
20) 21 (27) .31
48) 37 (47) .89
Figure 1. Survival following repair of rAAA by operation.
446 G.K. Ambler et al.p < .001). The adjusted odds ratio of severe AKI predicted
by the median difference in serum creatinine of
26 mmol L1 was 1.34 (95% CI 1.14e1.59). Ninety-three
(74%) patients treated with OSR had a preoperative CT
scan. There was no signiﬁcant increase in the rate of severe
AKI in these patients (45% vs. 37%, p ¼ 0.39). Data on
contrast volume used during EVAR were available for 60 of
the 74 patients treated with EVAR who survived at least 24
hours. The median (IQR) contrast volume used was 200
(136e270) mL. EVAR patients suffering severe AKI had a
higher median volume of contrast used, but this difference
did not reach statistical signiﬁcance (median [IQR] volumes
for patients with and without severe AKI 270 [158e300] mL
and 200 [130e250] ml, respectively, p ¼ .10).
When patients in the OSR group with LOC score greater
than zero were excluded from analysis, the difference in
incidence of severe AKI between OSR and EVAR groups was
no longer signiﬁcant (37% vs. 26%, adjusted p ¼ .25)
Mortality
Overall 30-day mortality was 21.5%, which increased to
30.9% at 12 months. There were no signiﬁcant differences
in unadjusted survival between those treated with EVAR
and those treated with OSR at any time point. After
adjustment for the confounders age, gender, comorbidities,
and preoperative creatinine, however, there was a signiﬁ-
cant 30-day survival advantage for those treated with EVAR
over those treated with OSR (16.2% in the EVAR group
versus 24.8%; hazard ratio 2.2, 95% CI 1.1e4.6, p ¼ .03),
although this had disappeared by 12 months (28.8%
compared with 32.2% in the OSR group; hazard ratio 1.4,
95% CI 0.8e2.5, p ¼ .20). When preoperative haemody-
namic variables were included in the confounder adjust-
ment model, even the small early survival beneﬁt of EVAR
disappeared. KaplaneMeier survival curves are shown in
Fig. 1.
Patients suffering severe AKI or requiring renal replace-
ment therapy had signiﬁcantly higher mortality at 30 days,
12 months, and overall (Table 3, Fig. 2; p < .001 for all
comparisons).
Length of stay
The median length of stay in the study cohort was 12 days
(IQR 6e25 days). This was signiﬁcantly longer in the OSR
group (median 14 days, IQR 7e27 days) than the EVAR group
(median 8.5 days, IQR 5e16.5 days, p < 0.01). Patients
suffering severe AKI or requiring renal replacement therapy
had signiﬁcantly prolonged length of stay, independent of
which type of repair was performed (Table 3; p < .001 for
both comparisons). The effects of operation and AKI on
length of stay persisted after adjustment for confounders,
including haemodynamic instability (p < .001).
Clamp level in the OSR group
In the subgroup treated with OSR, clamp site was recorded
in 123/125 cases. A supra-coeliac clamp (LOC score ¼ 3)
was used initially in 43 cases (35%), but in all but ﬁve ofthese cases this initial clamp was moved to a lower level
following dissection. In 94 cases the clamp during anasto-
mosis was infra-renal (LOC score ¼ 0), in nine cases it was
trans-renal (LOC score ¼ 1) and in 15 cases it was supra-
renal (LOC score ¼ 2). A more proximal clamp position
(higher LOC score) during anastomosis was signiﬁcantly
associated with adverse outcome, including increased
mortality at 30 days (p ¼ .01) and 12 months (p ¼ .03); an
increased risk of severe AKI (p < .01); and prolonged length
of stay (p < 0.001) after correction for confounders. This
was especially apparent in the small group of patients who
required a supra-coeliac clamp during anastomosis, none of
whom survived more than 24 hours. In contrast, the level of
initial clamping was not predictive of either mortality or
severe acute kidney injury. Data comparing LOC score dur-
ing anastomosis with the incidence of severe AKI and the
need for RRT are presented in Table 4. Correcting for LOC
score during anastomosis did not alter the association be-
tween severe AKI and survival or prolonged length of stay.
Division of the left renal vein and graft type (tube or
otherwise) were not associated with outcome.
DISCUSSION
This study has shown that severe AKI is common following
rAAA repair, affecting over a third of patients who survived
the ﬁrst 24 hours from the cohort, which includes renal
outcomes from the largest cohort of rAAA patients treated
endovascularly in the literature to date. AKI was more
common in patients undergoing OSR than it was in patients
treated endovascularly, despite the substantial increase in
contrast load in these patients, suggesting that contrast
nephropathy is not a major cause of renal dysfunction in
this cohort. This is in sharp contrast to early work on
endovascular repair of rAAA, where small studies showed
signiﬁcantly worse renal outcomes in patients treated with
EVAR.15 This difference persisted when patients treated
Table 3. Effect of severe AKI or requirement for RRT (renal replacement therapy) on mortality and length of stay.
Outcome ARISe < 3 Severe AKI (ARISe 3e5) RRT p (severe AKI) p (RRT)
30-day mortality (%) 5 28 33 <.001 <.001
12-month mortality 13 44 52 <.001 <.001
Length of stay: median (IQR) 10 (7e18) 26 (13e40) 25 (11e44) <.001 <.001
Severe Renal Impairment following ruptured AAA repair 447with OSR with a higher LOC score during anastomosis were
excluded, although the difference was no longer statistically
signiﬁcant. Perhaps unsurprisingly, patients suffering from
AKI experienced substantially longer hospital stays and
higher 30-day and 12-month mortality rates.
The issue of AKI after rAAA repair was recently studied in
a large Dutch series16 consisting mainly of patients treated
with OSR, and using the RIFLE12 classiﬁcation. Similar to the
present study, they found AKI to be common after rAAA
repair, and that those suffering from AKI suffered a higher
in-hospital/30-day mortality rate. This reinforced previous
work from smaller series before the endovascular era.17,18
The present work complements much previous work on
AKI after elective AAA repair19 and, together with the Dutch
study referred to above, strongly refutes the preconception
that contrast nephropathy is a signiﬁcant concern following
EVAR.
Results of the recent AJAX trial4 were also broadly similar,
although this trial has been criticised for the small number
of patients recruited, the long time period of recruitment,
and the small percentage of screened patients who were
deemed “suitable.”20
After adjusting for confounders, a signiﬁcant beneﬁt of
EVAR over OSR was found in terms of 30-day mortality,
although this disappeared at later time-points and after
adjustment for haemodynamic instability. This is in contrast
with the ﬁndings of both the AJAX trial4 and the much
larger IMPROVE trial,3 which both found no signiﬁcant
short-term beneﬁt of an endovascular strategy. It isFigure 2. Survival following repair of rAAA according to degree of
AKI. ARISe: Aneurysm Renal Injury Score.interesting to note that this difference disappeared once
haemodynamic parameters were taken into account,
implying that this may be a signiﬁcant confounder in pre-
vious case series which found in favour of an endovascular
strategy. One major beneﬁt of randomised studies is that
the randomisation process corrects for unmeasured con-
founders, so it is possible that this difference simply reﬂects
incomplete confounder adjustment. Few data are currently
available on renal outcomes in the IMPROVE trial popula-
tion. It would be interesting to compare the present results
with this randomised population.
This centre did participate in the IMPROVE trial, which
took place during part of the data collection period; how-
ever, only 33 of the 205 patients presented here were
randomised within the trial, so small differences in the
management of these patients compared with other pa-
tients in the study are unlikely to have a signiﬁcant impact
on the overall results.
In the elective setting, level of aortic clamping has pre-
viously been shown to adversely affect renal outcome in
small case series.21 The present study conﬁrms this ﬁnding
in the emergent setting, although it is interesting that the
use of a higher level clamp to gain control during dissection
did not have a signiﬁcant adverse impact on any of the
outcomes studied, implying that the use of this manoeuvre
to gain control during dissection is safe. The association of a
higher level of clamping with worse outcomes is also
concordant with recently presented data from the IMPROVE
trial, which suggests that infra-renal neck length may in-
ﬂuence outcomes in both open and endovascular patients
(personal communication).
The major strengths of the work include the size of the
database, which includes the largest cohort of acute renal
outcomes in patients treated endovascularly for rAAA in the
literature, the fact that the database has been prospectively
maintained and rigorously interrogated against the hospital
coding system to reduce the degree of recall bias, and the
length of follow-up, with a substantial proportion satisfying
the British Society of Endovascular Therapy reporting
standards deﬁnition of “long term.”22Table 4. Effect of aortic clamp level on acute renal outcomes.
LOC score during
anastomosis
Number of
patients
Incidence of
severe AKI (%)
Need for
RRT (%)
0 (infra-renal) 94 37 30
1 (trans-renal) 9 44 44
2 (supra-renal) 15 80 64
3 (higher level clamp) 5 - -
LOC ¼ Level Of Clamp.
Percentages in columns 3 and 4 are based on the 112 patients
treated with OSR who survived at least 24 hours.
No patients with LOC score ¼ 3 survived 24 hours.
448 G.K. Ambler et al.Weaknesses include some data on the patients being
collected from retrospective review of medical notes,
although the list of patients was maintained prospectively.
A further weakness is that mortality data rely somewhat on
the peculiarities of the death certiﬁcation system in England
and Wales, which has come under recent criticism as there
can occasionally be some time lag between the death of a
patient and certiﬁcation, as certiﬁcates are only issued after
the cause of death has been established.23 Finally, no ad-
justments were made for anatomic confounders as a
reasonable proportion of the patients in the OSR group had
no preoperative CT scan. Given previous reports of favour-
able outcomes even for patients treated with OSR if they
are suitable for EVAR, this effect may be signiﬁcant.24
Given the high rates of severe AKI identiﬁed in this and
other studies looking at patients following rAAA repair and
the poor outcomes of these patients, it is natural to suggest
that perhaps early renal replacement therapy might be
beneﬁcial in this cohort. There has been some work in pa-
tients following cardiac surgery which suggests that this
may indeed be an important intervention,25 and a rando-
mised controlled trial is under way to investigate this
question in patients with septic shock.26 Given the high
incidence of SIRS following rAAA repair,7 the results of this
trial may be transferrable to rAAA patients, but a rando-
mised trial of early versus delayed renal replacement ther-
apy in patients treated for rAAA would provide the best
evidence.
In conclusion, severe AKI is common in all patients
following repair of rAAA, but the endovascular treatment of
rAAA patients, when feasible, results in a lower incidence of
severe AKI despite administration of contrast medium. Pa-
tients suffering severe AKI have signiﬁcantly prolonged
lengths of stay and reduced short- and long-term survival.
Further work is needed to determine whether this high-risk
cohort would beneﬁt from early renal replacement therapy.CONFLICT OF INTEREST
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